相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis
Naomie Turgeon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts
Anke Nijhuis et al.
CLINICAL SCIENCE (2014)
Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+ T Cell Polarization in Vitro and in Vivo
Rainer Glauben et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
Pamela V. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chemopreventive Effects of an HDAC2-Selective Inhibitor on Rat Colon Carcinogenesis and APCmin/+ Mouse Intestinal Tumorigenesis
Durgadevi Ravillah et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
Richard D. W. Kelly et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
Tianzhu Qiu et al.
FUTURE ONCOLOGY (2013)
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Nicholas T. Ventham et al.
GASTROENTEROLOGY (2013)
Mucosal Healing in Crohn's Disease: A Systematic Review
Peter De Cruz et al.
INFLAMMATORY BOWEL DISEASES (2013)
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis
Theresa Alenghat et al.
NATURE (2013)
Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes
J. H. Wang et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
HDAC1 and HDAC2 Restrain the Intestinal Inflammatory Response by Regulating Intestinal Epithelial Cell Differentiation
Naomie Turgeon et al.
PLOS ONE (2013)
Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
Christina E. Wells et al.
PLOS ONE (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF alpha Agents
Luisa Guidi et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs
Melissa D. Cantley et al.
INFLAMMOPHARMACOLOGY (2013)
Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells
Mary A. Zimmerman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
Aleksander M. Grabiec et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients
Justin Gillespie et al.
ARTHRITIS AND RHEUMATISM (2012)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
Multiple roles of class I HDACs in proliferation, differentiation, and development
Nina Reichert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Disability in Inflammatory Bowel Disease
Bincy P. Abraham et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC
Zhi-Ning Zhao et al.
PLOS ONE (2012)
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages
Xuefen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Histone Deacetylases 6 and 9 and Sirtuin-1 Control Foxp3+ Regulatory T Cell Function Through Shared and Isoform-Specific Mechanisms
Ulf H. Beier et al.
SCIENCE SIGNALING (2012)
Substance P Induces CCN1 Expression via Histone Deacetylase Activity in Human Colonic Epithelial Cells
Hon Wai Koon et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
W. P. Yong et al.
ANNALS OF ONCOLOGY (2011)
Safety and Efficacy of an Oral Histone Deacetylase Inhibitor in Systemic-Onset Juvenile Idiopathic Arthritis
Jelena Vojinovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Differential patterns of histone acetylation in inflammatory bowel diseases
Loukia G. Tsaprouni et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
Edwin F. de Zoeten et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases
Rainer Glauben et al.
MOLECULAR MEDICINE (2011)
The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
Sonja Mandl-Weber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway
Davide Cacchiarelli et al.
CELL METABOLISM (2010)
Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice
Edwin F. de Zoeten et al.
GASTROENTEROLOGY (2010)
Peripheral Regulatory T Cells and Serum Transforming Growth Factor-β: Relationship with Clinical Response to Infliximab in Crohn's Disease
Antonio Di Sabatino et al.
INFLAMMATORY BOWEL DISEASES (2010)
Conditional Deletion of Histone Deacetylase 1 in T Cells Leads to Enhanced Airway Inflammation and Increased Th2 Cytokine Production
Reinhard Grausenburger et al.
JOURNAL OF IMMUNOLOGY (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis
Tomoko Kawabata et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages
Sang-Bae Han et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Janine Arts et al.
CLINICAL CANCER RESEARCH (2009)
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Richard L. Piekarz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
Isoform-selective histone deacetylase inhibitors
Anton V. Bieliauskas et al.
CHEMICAL SOCIETY REVIEWS (2008)
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
R. Glauben et al.
GUT (2008)
The dietary histone deacetylase inhibitor sulforaphane induces human β-defensin-2 in intestinal epithelial cells
Markus Schwab et al.
IMMUNOLOGY (2008)
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo
Daniela Bosisio et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Combinatorial patterns of histone acetylations and methylations in the human genome
Zhibin Wang et al.
NATURE GENETICS (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Role for histone deacetylase 1 in human tumor cell proliferation
Silvia Senese et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
CLINICAL CANCER RESEARCH (2007)
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Arianna Nenci et al.
NATURE (2007)
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
RB Sartor
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats
M Song et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Rapid alteration of microRNA levels by histone deacetylase inhibition
GK Scott et al.
CANCER RESEARCH (2006)
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1
BH Huang et al.
CELL DEATH AND DIFFERENTIATION (2005)
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases
J Mudter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
SJ Haggarty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
GD Kao et al.
JOURNAL OF CELL BIOLOGY (2003)
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis:: results of a multicentre trial
P Vernia et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Duration of nuclear NF-κB action regulated by reversible acetylation
LF Chen et al.
SCIENCE (2001)
Effect of sodium butyrate on reactive oxygen species generation by human neutrophils
Q Liu et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease
JP Segain et al.
GUT (2000)
分享论文
